Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Basic Research in Cardiology
Metadata
Title
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury
Authors
Dr. E. F. du Toit
M. Nabben
A. Lochner
Publication date
01-07-2005
Publisher
Steinkopff-Verlag
Published in
Basic Research in Cardiology / Issue 4/2005
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-005-0528-5

Other articles of this Issue 4/2005

Basic Research in Cardiology 4/2005 Go to the issue

ORIGINAL CONTRIBUTION

Parathyroid hormone–related peptide improves contractile responsiveness of adult rat cardiomyocytes with depressed cell function irrespectively of oxidative inhibition

ORIGINAL CONTRIBUTION

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3

ORIGINAL CONTRIBUTION

End–diastolic myofiber stress and ejection strain increase with ventricular volume overload

ORIGINAL CONTRIBUTION

Cardioprotection following adenosine kinase inhibition in rat hearts

ORIGINAL CONTRIBUTION

Design–based stereological estimation of the total number of cardiac myocytes in histological sections

MEETING REPORT

Protecting the myocardium at time of reperfusion

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits